Sotagliflozin (SGLT-2) in Conjunction with Insulin for T1D Reduces Average Glucose Levels
Less Insulin for Patients With Type 2 That Add On An SGLT2 Inhibitor
Empagliflozin’s Effect on Liver Fat
When and When Not to Use An SGLT-2